The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis
Open accessAbstract
The natural history of primary sclerosing cholangitis was assessed in 174 patients; 37 were asymptomatic and 137 had symptoms related to underlying liver disease. At the time of diagnosis, the mean age was 39.9 years, 66% of the primary sclerosing cholangitis patients were male and 71% had associated inflammatory bowel disease, most commonly chronic ulcerative colitis. Longterm follow-up (mean: 6.0 years; range: 2.7 to 15.5 years) was available in all patients. During follow-up, 59 (34%) of the patients died: 55 in the symptomatic group and four in the asymptomatic group. Median survival from the time of diagnosis of primary sclerosing cholangitis at the Mayo Clinic was 11.9 years. Survival in the asymptomatic group was significantly decreased compared with that in a control population matched for age, race and sex. Multivariate analysis (Cox proportional hazards regression modeling) revealed that age, serum bilirubin concentration, blood hemoglobin concentration, presence or absence of inflammatory bowel disease and histologic stage on liver biopsy were independent predictors of high risk of dying. The development of a multivariate statistical survival model is a major step in identifying individual primary sclerosing cholangitis patients at low, moderate and high risk of dying. Such models will be useful for stratifying patients in therapeutic trials, in patient counseling and in patient selection and timing of liver transplantation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Compensated cirrhosis: Natural history and prognostic factors
Ginés, P., Quintero, E., Arroyo, V., Terés, J., Bruguera, M., Rimola, A., Caballería, J., Rodés, J., & Rozman, C. (1987) · Hepatology · doi:10.1002/hep.1840070124 · Cited by 1,106
Chapman, R. W., Arborgh, B. A., Rhodes, J. M., Summerfield, J. A., Dick, R., Scheuer, P. J., & Sherlock, S. (1980) · Gut · doi:10.1136/gut.21.10.870 · Cited by 732
Clinicopathologic features of the syndrome of primary sclerosing cholangitis
Wiesner, R. H., & LaRusso, N. F. (1980) · Gastroenterology · doi:10.1016/0016-5085(80)90131-6 · Cited by 550
Self-citationBeneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis
Christensen, E., Neuberger, J., Crowe, J., Altman, D. G., Popper, H., Portmann, B., Doniach, D., Ranek, L., Tygstrup, N., & Williams, R. (1985) · Gastroenterology · doi:10.1016/0016-5085(85)90213-6 · Cited by 423
Roll, J., Boyer, J. L., Barry, D., & Klatskin, G. (1983) · New England Journal of Medicine · doi:10.1056/nejm198301063080101 · Cited by 417
Multivariate survival analysis using Cox's regression model
Christensen, E. (1987) · Hepatology · doi:10.1002/hep.1840070628 · Cited by 366
Primary Sclerosing Cholangitis
LaRusso, N. F., Wiesner, R. H., Ludwig, J., & MacCarty, R. L. (1984) · New England Journal of Medicine · doi:10.1056/nejm198404053101407 · Cited by 353
Self-citationPrimary Sclerosing Cholangitis: A Long-Term Follow-up Study
Aadland, E., Schrumpf, E., Fausa, O., Elgjo, K., Heilo, A., Aakhus, T., & Gjone, E. (1987) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528709011139 · Cited by 276
Orthotopic Liver Transplantation for Primary Sclerosing Cholangitis
MARSH, J. W., IWATSUKI, S., MAKOWKA, L., ESQUIVEL, C. O., GORDON, R. D., TODO, S., TZAKIS, A., MILLER, C., THIEL, D. V., & STARZL, T. E. (1988) · Annals of Surgery · doi:10.1097/00000658-198801000-00005 · Cited by 253
SUGI supplemental library user's guide
Hastings, R. P. (1986) · SAS Institute eBooks · Cited by 228
Cited by
Diagnosis and Management of Primary Sclerosing Cholangitis
Chapman, R., Fevery, J., Kalloo, A., Nagorney, D. M., Boberg, K. M., Shneider, B., & Gores, G. J. (2010) · Hepatology · doi:10.1002/hep.23294 · Cited by 1,224
Primary sclerosing cholangitis – a comprehensive review
Karlsen, T. H., Folseraas, T., Thorburn, D., & Vesterhus, M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.07.022 · Cited by 868
MELD and PELD: Application of survival models to liver allocation
Wiesner, R. H., McDiarmid, S. V., Kamath, P. S., Edwards, E. B., Malinchoc, M., Kremers, W. K., Krom, R. A. F., & Kim, R. W. (2001) · Liver Transplantation · doi:10.1053/jlts.2001.25879 · Cited by 864
Self-citationNatural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.
Broomé, U., Olsson, R., Lööf, L., Bodemar, G., Hultcrantz, R., Danielsson, A., Prytz, H., Sandberg-Gertzén, H., Wallerstedt, S., & Lindberg, G. (1996) · Gut · doi:10.1136/gut.38.4.610 · Cited by 819
High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis
Lindor, K. D., Kowdley, K. V., Luketic, V. A. C., Harrison, E. M., McCashland, T., Befeler, A. S., Harnois, D., Jorgensen, R., Petz, J., Keach, J., et al. (2009) · Hepatology · doi:10.1002/hep.23082 · Cited by 720
Boonstra, K., Weersma, R. K., van Erpecum, K. J., Rauws, E. A., Spanier, B. W. M., Poen, A. C., van Nieuwkerk, K. M., Drenth, J. P., Witteman, B. J., Tuynman, H. A., et al. (2013) · Hepatology · doi:10.1002/hep.26565 · Cited by 725
“Some studies used death from any cause as endpoint for Kaplan-Meier’s analysis.(5,7,9,10,25) When we included all deaths in the analysis, the estimated median survival until LT or death was 20.”
MethodHepatic and extrahepatic malignancies in primary sclerosing cholangitis
Bergquist, A., Ekbom, A., Olsson, R., Kornfeldt, D., Lööf, L., Danielsson, Å., Hultcrantz, R., Lindgren, S., Prytz, H., Sandberg-Gertzén, H., et al. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00288-4 · Cited by 717
Gregorio, G. (2001) · Hepatology · doi:10.1053/jhep.2001.22131 · Cited by 692
Primary sclerosing cholangitis
Hirschfield, G. M., Karlsen, T. H., Lindor, K. D., & Adams, D. H. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60096-3 · Cited by 592
Incidence and Risk Factors for Cholangiocarcinoma in Primary Sclerosing Cholangitis
Burak, K., Angulo, P., Pasha, T. M., Egan, K., Petz, J., & Lindor, K. D. (2004) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04067.x · Cited by 557
ACG clinical guideline: primary sclerosing cholangitis
Lindor, K. D., Kowdley, K. V., & Harrison, E. M. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.112 · Cited by 524
Weismüller, T. J., Trivedi, P. J., Bergquist, A., Imam, M., Lenzen, H., Ponsioen, C. Y., Holm, K., Gotthardt, D., Färkkilä, M. A., Marschall, H.-U., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.02.038 · Cited by 533
Primary Sclerosing Cholangitis
Lee, Y.-M., & Kaplan, M. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504063321406 · Cited by 526
Primary sclerosing cholangitis and ulcerative colitis: Evidence for increased neoplastic potential
Broomé, U., Löfberg, R., Veress, B., & Eriksson, L. S. (1995) · Hepatology · doi:10.1002/hep.1840220511 · Cited by 481
Natural history and prognostic variables in primary sclerosing cholangitis
Farrant, J. M., Hayllar, K. M., Wilkinson, M. L., Karani, J., Portmann, B. C., Westaby, D., & Williams, R. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90673-9 · Cited by 468
Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease
Kamisawa, T., & Okamoto, A. (2006) · Journal of Gastroenterology · doi:10.1007/s00535-006-1862-6 · Cited by 466
Primary sclerosing cholangitis
Dyson, J. K., Beuers, U., Jones, D. E. J., Lohse, A. W., & Hudson, M. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30300-3 · Cited by 462
IgG4-related sclerosing disease
Kamisawa, T., & Okamoto, A. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.3948 · Cited by 458
Bambha, K., Kim, W. R., Talwalkar, J., Torgerson, H., Benson, J. T., Therneau, T. M., Loftus, E. V., Yawn, B. P., Dickson, E. R., & Melton, L. J. (2003) · Gastroenterology · doi:10.1016/j.gastro.2003.07.011 · Cited by 450
Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial
Beuers, U., Spengler, U., Kruis, W., Aydemir, Ü., Wiebecke, B., Heldwein, W., Weinzierl, M., Pape, G. R., Sauerbruch, T., & Paumgartner, G. (1992) · Hepatology · doi:10.1002/hep.1840160315 · Cited by 448
A Revised Natural History Model for Primary Sclerosing Cholangitis
KIM, W. R., THERNEAU, T. M., WIESNER, R. H., POTERUCHA, J. J., BENSON, J. T., MALINCHOC, M., LARUSSO, N. F., LINDOR, K. D., & DICKSON, E. R. (2000) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)64614-4 · Cited by 434
Self-citationAASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma
Bowlus, C. L., Arrivé, L., Bergquist, A., Deneau, M., Forman, L., Ilyas, S. I., Lunsford, K. E., Martinez, M., Sapisochin, G., Shroff, R., et al. (2023) · Hepatology · doi:10.1002/hep.32771 · Cited by 428
Tischendorf, J. J. W., Hecker, H., Krüger, M., Manns, M. P., & Meier, P. N. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00872.x · Cited by 413
EASL Clinical Practice Guidelines on sclerosing cholangitis
Chazouilleres, O., Beuers, U., Bergquist, A., Karlsen, T. H., Levy, C., Samyn, M., Schramm, C., & Trauner, M. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.05.011 · Cited by 419
Extraintestinal manifestations in inflammatory bowel disease
Danese, S. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i46.7227 · Cited by 373
Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis
Graziadei, I. W., Wiesner, R. H., Marotta, P. J., Porayko, M. K., Hay, E. J., Charlton, M. R., Poterucha, J. J., Rosen, C. B., Gores, G. J., LaRusso, N. F., et al. (1999) · Hepatology · doi:10.1002/hep.510300501 · Cited by 359
Self-citationA preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis
Mitchell, S. A., Bansi, D. S., Hunt, N., Bergmann, K. V., Fleming, K. A., & Chapman, R. W. (2001) · Gastroenterology · doi:10.1053/gast.2001.27965 · Cited by 351
Cholangiocarcinoma in patients with primary sclerosing cholangitis: A multicenter case-control study
Chalasani, N., Baluyut, A., Ismail, A., Zaman, A., Sood, G., Ghalib, R., McCashland, T. M., Reddy, R. K., Zervos, X., Anbari, M. A., et al. (2000) · Hepatology · doi:10.1002/hep.510310103 · Cited by 336
Birrenbach, T., & Böcker, U. (2004) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200411000-00019 · Cited by 321
Drugs and the liver part 1: Testing liver function
Sallie, R., Michael Tredger, J., & Williams, R. (1991) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2510120403 · Cited by 311
Cholangiocarcinoma in Primary Sclerosing Cholangitis: Risk Factors and Clinical Presentation
Boberg, K. M., Bergquist, A., Mitchell, S., Pares, A., Rosina, F., Broomé, U., Chapman, R., Fausa, O., Egeland, T., Rocca, G., et al. (2002) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655202760373434 · Cited by 311
The natural history of small-duct primary sclerosing cholangitis
Björnsson, E., Olsson, R., Bergquist, A., Lindgren, S., Braden, B., Chapman, R. W., Boberg, K. M., & Angulo, P. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.042 · Cited by 305
Corpechot, C., Gaouar, F., El Naggar, A., Kemgang, A., Wendum, D., Poupon, R., Carrat, F., & Chazouillères, O. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.12.030 · Cited by 300
Chapman, M. H., Thorburn, D., Hirschfield, G. M., Webster, G. G. J., Rushbrook, S. M., Alexander, G., Collier, J., Dyson, J. K., Jones, D. E., Patanwala, I., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-317993 · Cited by 284
Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis
Ramage, J. K., Donaghy, A., Farrant, J. M., Iorns, R., & Williams, R. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90462-x · Cited by 279
Bergquist, A., Glaumann, H., Persson, B., & Broomé, U. (1998) · Hepatology · doi:10.1002/hep.510270201 · Cited by 281
Kaplan, G. G., Laupland, K. B., Butzner, D., Urbanski, S. J., & Lee, S. S. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01103.x · Cited by 273
Primary sclerosing cholangitis: Refinement and validation of survival models
Dickson, E. R., Murtaugh, P. A., Wiesner, R. H., Grambsch, P. M., Fleming, T. R., Ludwig, J., LaRusso, N. F., Malinchoc, M., Chapman, R. W., Kaplan, M. M., et al. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91449-e · Cited by 270
Self-citationPonsioen, C. Y., Vrouenraets, S. M. E., Prawirodirdjo, W., Rajaram, R., Rauws, E. A. J., Mulder, C. J. J., Reitsma, J. B., Heisterkamp, S. H., & Tytgat, G. N. J. (2002) · Gut · doi:10.1136/gut.51.4.562 · Cited by 268
Tabibian, J. H., Weeding, E., Jorgensen, R. A., Petz, J. L., Keach, J. C., Talwalkar, J. A., & Lindor, K. D. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12232 · Cited by 267
Wight, D. G. D. (1993) · Atlas of Liver Pathology · doi:10.1007/978-94-011-2212-2_20 · Cited by 261
Primary Sclerosing Cholangitis in Children: A Long–Term Follow–Up Study
Feldstein, A. E., Perrault, J., El-Youssif, M., Lindor, K. D., Freese, D. K., & Angulo, P. (2003) · Hepatology · doi:10.1053/jhep.2003.50289 · Cited by 256
Tabibian, J. H., O'Hara, S. P., Splinter, P. L., Trussoni, C. E., & LaRusso, N. F. (2014) · Hepatology · doi:10.1002/hep.26993 · Cited by 241
Self-citationSmall-duct primary sclerosing cholangitis: a long-term follow-up study
Angulo, P., Maor-Kendler, Y., & Lindor, K. D. (2002) · Hepatology · doi:10.1053/jhep.2002.33202 · Cited by 213
Balloon dilation compared to stenting of dominant strictures in primary sclerosing cholangitis
Kaya, M., Petersen, B. T., Angulo, P., Baron, T. H., Andrews, J. C., Gostout, C. J., & Lindor, K. D. (2001) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03690.x · Cited by 196
Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis
Boberg, K. M., Jebsen, P., Clausen, O. P., Foss, A., Aabakken, L., & Schrumpf, E. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.05.010 · Cited by 159
Broomé, U., Glaumann, H., Hellers, G., Nilsson, B., Sörstad, J., & Hultcrantz, R. (1994) · Gut · doi:10.1136/gut.35.1.84 · Cited by 147
Broomé, U., Glaumann, H., Lindstöm, E., Lööf, L., Almer, S., Prytz, H., Sandberg-Gertzén, H., Lindgren, S., Fork, F.-T., Järnerot, G., et al. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00036-3 · Cited by 131
Primary sclerosing cholangitis: diagnosis, prognosis, and management
Singh, S., & Talwalkar, J. A. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.02.016 · Cited by 119
de Valle, M. B., Björnsson, E., & Lindkvist, B. (2012) · Liver International · doi:10.1111/j.1478-3231.2011.02614.x · Cited by 114
Hultcrantz, R., Olsson, R., Danielsson, Å., Järnerot, G., Lööf, L., Ryden, B. O., Wahren, B., & Broomé, U. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80198-6 · Cited by 107
Ponsioen, C. Y., Assis, D. N., Boberg, K. M., Bowlus, C. L., Deneau, M., Thorburn, D., Aabakken, L., Färkkilä, M., Petersen, B., Rupp, C., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.07.046 · Cited by 95
Role of the Microbiota and Antibiotics in Primary Sclerosing Cholangitis
Tabibian, J. H., Talwalkar, J. A., & Lindor, K. D. (2013) · BioMed Research International · doi:10.1155/2013/389537 · Cited by 91
de Vries, E. M. G., Färkkilä, M., Milkiewicz, P., Hov, J. R., Eksteen, B., Thorburn, D., Chazouillères, O., Pares, A., Nygård, S., Gilja, O. H., et al. (2017) · Liver International · doi:10.1111/liv.13402 · Cited by 83
Kartheuser, A. H., Dozois, R. R., Larusso, N. F., Wiesner, R. H., Lstrup, D. M., & Schleck, C. D. (1996) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)64839-8 · Cited by 74
Self-citationBrandsæter, B., Broomé, U., Isoniemi, H., Friman, S., Hansen, B., Schrumpf, E., Oksanen, A., Ericzon, B.-G., Höckerstedt, K., Mäkisalo, H., et al. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50169 · Cited by 71
Jørgensen, K. K., Lindström, L., Cvancarova, M., Castedal, M., Friman, S., Schrumpf, E., Foss, A., Isoniemi, H., Nordin, A., Holte, K., et al. (2012) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2012.685754 · Cited by 65
Risk of waitlist mortality in patients with primary sclerosing cholangitis and bacterial cholangitis
Goldberg, D. S., Camp, A., Martinez-Camacho, A., Forman, L., Fortune, B., & Reddy, R. K. (2013) · Liver Transplantation · doi:10.1002/lt.23587 · Cited by 58
“9 years.(13) With earlier diagnosis due to an increased awareness of the disease, the availability of noninvasive imaging of the biliary tree, the increased use of routine liver enzyme evaluation in asymptomatic patients, and the recognition of the association between IBD and PSC, more asymptomatic cases are being det…”
BackgroundEtiology and pathogenesis in primary sclerosing cholangitis
Boberg, K. M., Lundin, K. E. A., & Schrumpf, E. (1994) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529409103625 · Cited by 53
Tabibian, J. H., & Lindor, K. D. (2014) · Hepatology · doi:10.1002/hep.27180 · Cited by 42
Complications, symptoms, quality of life and pregnancy in cholestatic liver disease
Zakharia, K., Tabibian, A., Lindor, K. D., & Tabibian, J. H. (2018) · Liver International · doi:10.1111/liv.13591 · Cited by 42
Epigenetics in the primary biliary cholangitis and primary sclerosing cholangitis
Cheung, A., LaRusso, N., Gores, G., & Lazaridis, K. (2017) · Seminars in Liver Disease · doi:10.1055/s-0037-1603324 · Cited by 37
Self-citationWang, M.-H., Mousa, O. Y., Friton, J. J., Raffals, L. E., Leighton, J. A., Pasha, S. F., Picco, M. F., Cushing, K. C., Monroe, K., Nix, B. D., et al. (2020) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz209 · Cited by 27
Utility of Noninvasive Markers of Fibrosis in Cholestatic Liver Diseases
Corpechot, C. (2016) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.08.013 · Cited by 19
Khan, N., Trivedi, C., Shah, Y., Cole, E., Lewis, J., & Yang, Y.-X. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy106 · Cited by 18
Trivedi, P. J. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.08.013 · Cited by 14
Metadata
- Authors
- Wiesner, R. H., Grambsch, P. M., Dickson, R. E., Ludwig, J., Maccarty, R. L., Hunter, E. B., Fleming, T. R., Fisher, L. D., Beaver, S. J., & Larusso, N. F.
- Venue
- Hepatology
- Published
- 1989-10
- Volume
- 10
- Issue
- 4
- Pages
- 430-436
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1996463505
- Cited by
- 643
- References
- 25
- FWCI
- 8.14
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.